P

Inventor

TAYLOR STEVEN JOHN

US12 patents
⚠️ This page may combine multiple inventors who share the name “TAYLOR STEVEN JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FLAGSHIP PIONEERING INNOVATIONS V INC

5 patents
US10953027B2Mar 23, 2021

Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease

FLAGSHIP PIONEERING INNOVATIONS V INC3 citations68
US12115178B2Oct 15, 2024

Acylated active agents and methods of their use for the treatment of autoimmune disorders

FLAGSHIP PIONEERING INNOVATIONS V INC0 citations57
US11813272B2Nov 14, 2023

Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease

FLAGSHIP PIONEERING INNOVATIONS V INC0 citations57
US11058698B2Jul 13, 2021

Acylated active agents and methods of their use for the treatment of autoimmune disorders

FLAGSHIP PIONEERING INNOVATIONS V INC0 citations57
US11998610B2Jun 4, 2024

Conjugates and methods of using the same

FLAGSHIP PIONEERING INNOVATIONS V INC0 citations51

ABEYWARDANE ASITHA

4 patents
US8785489B2Jul 22, 2014

Heteroaryl substituted indole compounds useful as MMP-13 inhibitors

ABEYWARDANE ASITHA4 citations68
US9150556B2Oct 6, 2015

Benzimidazolone chymase inhibitors

ABEYWARDANE ASITHA1 citations50
US8969348B2Mar 3, 2015

Chymase inhibitors

ABEYWARDANE ASITHA0 citations50
US9403830B2Aug 2, 2016

Inhibitors of leukotriene production

ABEYWARDANE ASITHA0 citations40

FARROW NEIL ALEXANDER

1 patent
US8637550B2Jan 28, 2014

Heteroaryl diamide compounds useful as MMP-13 inhibitors

FARROW NEIL ALEXANDER2 citations54

SAIL BIOMEDICINES INC

1 patent
US12570638B2Mar 10, 2026

Fused imidazole derivatives as AHR antagonists

SAIL BIOMEDICINES INC0 citations50

HEIM-RIETHER ALEXANDER

1 patent
US9139567B2Sep 22, 2015

Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase

HEIM-RIETHER ALEXANDER0 citations35